Streptolysin S exists in a cell-bound form and as an extracellular complex between a nonspecific carrier (serum, serum albumin, ribonucleic acid [RNA], Triton, Tween) and a hemolytic moiety (probably a peptide) synthesized by streptococci. Although all the forms of streptolysin S, at 100 hemolytic units, killed mouse leukocyte monolayers, the time needed to kill 100% of the cells varied with the different streptolysin S preparations. Whereas 30 min was sufficient for the cell-bound hemolysin to kill all of the cells, 60 and 180 min were required when RNA streptolysin S and serum streptolysin S, respectively, were employed. Addition of 10% mouse serum to RNA streptolysin S or to cell-bound hemolysin delayed the killing of the leukocytes. The delayed killing observed with serum and albumin hemolysins is probably due to competition for the hemolytic moiety between the carrier molecules and target sites (phospholipids) upon the leukocyte membrane. Serum streptolysin S must be constantly incubated with the cells for 90 min for 100% of the cells to undergo cytopathic changes upon subsequent incubation for an additional 90 min. Streptolysin S inhibitor (trypan blue) added to the system after 30 or 60 min of incubation resulted in the killing of 50 and 100% of the leukocytes, respectively, when the cells were further incubated for 120 min. It is suggested that 30 min of incubation was not sufficient for the transfer of enough streptolysin S molecules upon the cell surface to allow killing of all of the cells. Sublethal amounts of streptolysin S, streptolysin 0, and saponin suppressed phagocytosis of streptococci by mouse peritoneal macrophages. This effect was abolished by inhibitors of streptolysin S (trypan blue) and of streptolysin 0 and saponin (cholesterol). With sublethal amounts of streptolysin S, no inhibition of the reduction of nitro blue tetrazolium by nonphagocytosing cells was observed, but these amounts of streptolysin S caused a 50% inhibition of the reduction of nitro blue tetrazolium by phagocytosing leukocytes. It is suggested that some metabolic systems, which are normally enhanced during phagocytosis, have been affected by sublethal doses of streptolysin S. The results indicate that the in vivo production of small amounts of streptolysins S and 0 by group A streptococci may inhibit phagocytosis and may thus contribute to the invasiveness and pathogenicity of this microorganism.
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The hemolytic and cytotoxic properties of streptococcal filtrates have been shown to be associated with two extracellular hemolytic substances: streptolysin 0 and streptolysin S (3, 5, 11, 14, 18, 19, 21, 26, 28, 30) . Whereas streptolysin 0 is an immunogenic, SH-dependent protein (18, 19, 28) , streptolysin S is nonimmunogenic and is considered to be a complex between nonspecific carrier molecules (ribonucleic acid [RNA] , albumin, alpha-lipoprotein, Tween, Triton, trypan blue, etc.) and a hemolytic moiety (probably a peptide) synthesized by streptococci (11) . Transfer of the hemolytic moiety of streptolysin S from one carrier to another depends on the relative affinities of the carriers for the hemolytic peptide (15) . It has also been shown that the classical serum hemolysin is largely the hemolysin produced by serum albumin (11, 15) . Furthermore, it has been found that washed streptococci possess a cell-bound hemolytic factor (13) , probably identical with the leukotoxic factor (25) , which can be released from the bacterial cells by any of the above-mentioned carriers. Thus, the cell-bound hemolysin is probably identical with the cell-bound hemolytic moiety of streptolysin S (11) . Serum hemolysin (30) , albumin hemolysin (14) , RNA hemolysin (5, 20) , and cell-bound hemolysin (11, 14) have been reported to exert distinct cytopathic effects on mouse peritoneal leukocytes, but other investigators, by using serum hemolysin (19) and RNA hemolysin (14, 23, 26) experiments. This streptococcus is M-negative and had lost its capacity to resist phagocytosis. The streptococci were cultivated in brain heart infusion broth (Difco) at 37 C and were harvested at the end of the logarithmic phase of growth. The cells were washed in PBS (saline buffered with 0.05 M phosphate buffer, pH 7.4), and the cell suspension was adjusted to contain approximately 109 streptococci/mi. Preparation of streptolysins. Streptolysin S was prepared from resting cells as described previously (12, 17) . Briefly, the following agents were used to produce hemolytic activity: RNA-core (Worthington Biochemical Corp.), horse serum, bovine serum, rabbit serum, human serum, and mouse serum. To 5 ml of washed streptococci, 0.2 ml of an activation mixture (100 mg each of glucose and Mg2+ per ml and 10 mg of cysteine per ml) and 1.0 ml of one of the various sera or 25 mg of RNA-core were added. After 30 min of incubation at 37 C, the mixtures were centrifuged and the supernatant fluids were used as the source of hemolysin. Cell-bound hemolysin was assayed on washed streptococci as described previously (13) . Inhibition of the activity of the hemolysins was achieved by preincubation for 5 min at 37 C with 100
Ag of trypan blue/ml.
Streptolysin 0. In some experiments, a highly concentrated streptolysin 0 preparation was used (5) . In others, supematant fluid derived from the streptococcal cultures was used as a source of hemolysin. All preparations were assayed after activation with cysteine (10 mg/ml). Cholesterol (50,ug/ml) was used to inhibit hemolysin activity.
Streptococcal extracellular products. Extracellular products were obtained from the supernatant fluid of a type 4 streptococcal culture cultivated in a chemostat. A lyophilized preparation of streptococcal extracellular products was kindly supplied by T. N. Harris, Childrens Hospital, Philadelphia, Pa. This preparation did not possess any streptolysin activities.
Cell-sensitizing factor. Cell-sensitizing factor was extracted from washed streptococci with phenol as described previously (8, 24) . Sensitization of leukocytes with the factor and treatment of the sensitized leukocytes with anti-cell-sensitizing factor serum and complement were also done as described previously (8) .
Leukotoxicity assays. Peritoneal macrophages of Swiss mice weighing 20 g were used throughout. A monolayer of peritoneal macrophages containing 106 cells per cover slip were prepared as described previously (25) . To each cover slip, 0.2-ml amounts of the different hemolysin preparations or of cell-sensitizing factor were added. The final volume of the reaction mixture was adjusted to 1.0 ml with Hanks bovine albumin-glucose (HBG) medium (4). After various periods of incubation at 37 C in a moist chamber, 0.1 ml of 1%7 trypan blue was added. The percentage of dead leukocytes (which took up the dye) was determined by counting 300 cells (4) .
Determination of hemolytic and leukotoxic activities. One hemolytic unit (HU) of streptolysin S, streptolysin 0, or saponin (British Drug House) was determined as the reciprocal of the highest dilution or concentration of hemolysin which released 50% hemoglobin from a 2% suspension of human blood group 0 erythrocytes after 40 min of incubation at 37 C. Since various streptolysin preparations lysed leukocytes within a wide range of incubation periods (see below), it was impossible to standardize a leukotoxic unit as has been done in the hemolytic assays. Therefore, the time needed for 100 HU of each hemolysin preparation to kill 100% of a leukocyte monolayer was determined as a standard leukocidal activity of each hemolysin preparation.
Determination of phagocytosis. Phagocytosis was determined as described previously (4) . Briefly, the leukocyte monolayer (106/slide) was treated with the various hemolysin preparations or with suitable controls. The monolayers were washed with HBG medium, and 1.0 ml of a heat-killed streptococcal suspension (107/ml) was added. After 15 min at 37 C, the cover slips were washed, rinsed in 0.05% saline, dried, vertically fixed in methanol, and stained with Giemsa.
The degree of phagocytosis was determined by estimating the percentage of leukocytes which engulfed streptococci. This represents only an approximation of phagocytic activity, as many bacteria have been found to be cell-associated but not internalized.
Nitro blue tetazolium test. The nitro blue tetrazolium test was performed as described (by Baehmer and Nathan (2) with slight modifications. Briefly, 0.2-ml amounts of leukocyte suspensions containing either 107 or 4 X 107 cells were incubated with 0.2 ml of horse serum streptolysin S (100 HU/106 leukocytes) or with horse serum-PBS mixtures. After 60 min of incubation of 37 C in a shaker incubator, the leukocyte suspensions were washed twice with HBG medium and were resuspended in 0.4 ml of HBG medium; 0.4 ml of 0.1% nitro blue tetrazolium (grade III, Sigma Chemical Co., St. Louis, Mo.) in saline and 0.2 ml of HBG were then added. In phagocytosis experiments (107 cells), 0.2 ml of heat-killed streptococcal suspensions (40 Klett units) was added instead of HBG. The reaction mixtures were further incubated at 37 C in a shaker incubator, and the optical density of the reduced nitro blue tetrazolium was determined as described (2) .
RESULTS
Leukotoxic effect of streptolysin S. The leukotoxic effects of different hemolysin preparations on mouse peritoneal leukocytes is shown in Fig.  1 . Whereas 30 min of incubation at 37 C was sufficient for the cell-bound hemolysin and streptolysin 0 to kill 100%,C0 of the leukocytes, much longer periods of incubation were needed when the other forms of streptolysin S were employed. The slowest-acting preparations were those produced by mouse, rabbit, bovine, calf, or human sera. RNA hemolysin acted faster than any of the serum hemolysins. It was also found that addition of 10% of either mouse or rabbit serum to RNA hemolysin caused a great delay in its leukotoxic activity. These concentrations of sera did not, however, affect the hemolytic activity of the RNA hemolysin preparation.
Similarly, 10% mouse serum also caused a long delay (3 hr) in the killing of the cells by the cell-bound hemolysin, and bovin albumin (10 mg/ml) caused a 15-min delay in the hemolytic activity of the RNA hemolysin. On the other hand, mouse serum had no delaying effect on leukocytolysis induced by horse serum streptolysin S. The apparent lack of leukotoxicity observed when different forms of streptolysin S were employed (14, 19, 23, 26) that trypan blue is unable to inhibit the hemolysin which had already interacted with target sites on the cell membrane (16) .
The possibility that impairment of phagocytosis will also occur after treatment with sublethal amounts of streptolysin S or with doses showing a latent toxic effect was, therefore, studied.
Inhibition of phagocytosis by streptolysins. Horse and mouse serum hemolysins (100 HU/106 leukocytes), RNA hemolysin (20 HU/106 leukocytes), and streptolysin 0 (1 HU/106 leukocytes) were employed in phagocytosis inhibition tests. To examine the specificity of the effect of the 1-.
VOL. 6, 1972 streptolysin preparations on the cells, saponin (1 HU/106 leukocytes) was also employed. This hemolytic agent was found to cause histopathological lesions in mouse muscle indistinguishable from those induced by streptolysin S (3). In addition, the cell-sensitizing antigen of streptococci, known to sensitize leukocytes to lysis in the presence of antibodies to the cell-sensitizing antigen and complement (8) , and iodoacetic acid, known to inhibit phagocytosis (7), were also used in phagocytosis experiments.
The leukocyte monolayers were preincubated for 30 or 60 min at 37 C with the various agents. The concentrations of hemolytic agents used have been found not to exert cytophatic effects on the cells when incubated for the specified periods (see Fig. 1 ). The capacity of the leukocytes to engulf heat-killed streptococci was then determined. Table 1 shows that all of the hemolytic agents and iodoacetic acid, employed at sublethal concentrations, markedly inhibited phagocytosis of streptococci. Inhibition of the hemolytic activity of the streptolysins or of saponin, with their respective inhibitors, abolished the suppression of phagocytosis. Shorter preincubation (10 to 30 min) of streptolysin S with leukocytes (not shown in Table 1 ) resulted in a gradual decrease of phagocytosis inhibition. No inhibition of phagocytosis was, however, achieved after the sensitization of leukocytes with the cell-sensitizing antigen or after the addition of anti-cell-sensitizing serum to the sensitized cells. These results are in accord with the findings on the inhibition of phagocytosis by sublethal concentrations of endotoxins (6) and by certain metabolic inhibitors (7), as well as by antimacrophage serum (10) .
Effect of streptolysin S on reduction of nitro blue tetrazolium during phagocytosis. The reduction of nitro blue tetrazolium by leukocytes was markedly enhanced during phagocytosis (2) and paralleled the phagocytosis capacity of the cells. Since sublethal concentrations of streptolysin S markedly inhibited phagocytosis, the relation between phagocytosis inhibition and possible metabolic impairment of leukocytes by streptolysin S was investigated. Table 2 shows that resting leukocytes (4 X 107) treated with sublethal doses of streptolysin S continued to reduce nitro blue tetrazolium at the same rate as untreated cells. On the other hand, similar treatment of leukocytes engaged in phagocytosis resulted in a 50% decrease in nitro blue tetrazolium reduction as compared to untreated cells. DISCUSSION The purpose of the present investigation was to clarify the apparent discrepancy in the literature concerning the leukotoxicity of various streptolysin S preparations, and to study the effect of sublethal doses of streptolysin S on phagocytosis of streptococci by mouse peritoneal macrophages. The results of these studies revealed several points of interest. Although all preparations of streptolysin S employed at 100 HU/106 leukocytes killed the cells, the time needed to demonstrate leukotoxicity varied greatly with the different hemolysins. Thus, whereas 30 min was sufficient for washed streptococci possessing cell-bound hemolytic activity to kill 100% of the leukocytes, 60 and 180 min were required when RNA and serum hemolysins, respectively, were employed. The fact that the addition of 10%o mouse serum to RNA hemolysin or to cell-bound hemolysin resulted in a great retardation in leukotoxicity, and the finding that the lytic effect of RNA hemolysin on isolated leukocyte and granule mitochondria (29) was greatly retarded by albumin, all point to the role played by the carrier (2) .
molecules (used to prepare streptolysin S) in delaying the lysis of leukocytes. Under similar conditions, none of the carrier molecules had any delaying effects on the hemolytic properties of streptolysin S. As described previously (11) , streptolysin S is a labile complex between a nonspecific carrier (RNA, albumin, serum, Triton, Tween) and a specific hemolytic moiety (a peptide) synthesized by streptococci. It was also shown (15) that the hemolytic moiety could be transferred among the different carriers based on the relative affinities the different carriers have for the hemolytic peptide. Thus, the addition of large amounts of albumin to RNA hemolysin resulted in the transfer of the hemolytic moiety to albumin, leaving the bulk of RNA carrier devoid of hemolytic activity. Under similar conditions, serum globulin failed to compete in this reaction. However, the strongest affinity for the hemolytic moiety is shared by target sites (probably phospholipids) present in the red blood cell membrane (9) . It is therefore suggested that the binding affinities of target sites on white blood cells for streptolysin S are weaker than those on red blood cells, and that the competition which occurs between these cell targets and the serum protein carriers results in a delay in the transfer of the hemolytic moiety to the white blood cells. This assumption is also based on the findings that a much larger number of hemolytic units are needed to kill leukocytes as compared with red blood cells (11) , and that the leukocytes must be in contact with streptolysin S for prolonged periods before sufficient hemolysin is transferred onto the cell surface (Fig. 2) . It is therefore suggested that a definition of a leukotoxic unit should be made separately for each streptolysin S preparation depending on the nature of the carrier employed.
Both streptolysins 0 and S and saponin, all known to damage the cellular membrane, suppressed phagocytosis when employed at concentrations which did not cause an apparent cytopathic effect on the leukocytes. The mechanism by which phagocytosis was impaired by the hemolysins is not known, but several hypotheses may be forwarded to explain this phenomenon. It can be postulated that streptolysin S may penetrate into the cell interior, damage subcellular organelles (mitochondria, lysosomes; 20), and impair the metabolic functions of the cells which affect their phagocytic capacities. This assumption does not seem feasible, because passage of streptolysin S through the cell membrane would probably have caused permeability changes long before it could affect the integrity of the intracellular organelles (11) . Further support of this assumption is obtained from the experiments showing that no impairment of the reduction of nitro blue tetrazolium was demonstrated in cells affected by sublethal doses of hemolysins in nonphagocytosing cells. Another alternative is that sublethal doses of the hemolysins caused depolarization of the surface membrane, as has been shown for the action ofsublethal doses of streptolysin 0 (18, 27) and staphylococcal alpha-hemolysin (22) on heart cells and on leukocytes, respectively. These electrical changes may cause secondary metabolic impairments, which are not necessarily connected with alterations in the permeability of the outer membrane. The nature of these changes is, however, still not known. Very recent studies (1) have shown that sublethal amounts of streptolysin 0, shown by us to suppress phagocytosis, also abolish the chemotaxis of human neutrophils. In addition to preventing directional mobility, this hemolysin also suppressed the random migration of the cells. Since phagocytosis is probably closely associated with cell mobility, the suppression of both properties by streptococcal hemolysins may modify the host defenses at an early phase of infection and thus contribute to the invasiveness and pathogenicity of streptococci.
